Publications
Original Article
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation
Clinical Trials
2009
Authors:
Emens LA, Asquith JM, Leatherman JM, Kobrin BJ, Petrik S, Laiko M, Levi J, Daphtary MM, Biedrzycki B, Wolff AC, Stearns V, Disis ML, Ye X, Piantadosi S, Fetting JH, Davidson NE, Jaffee EM.
Journal:
Journal of Clinical Oncology
Volume:
27(35)
Page:
5911-8
Pubmed:
Original Article
Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer
Measuring Human Immunity
2009
Authors:
Dang Y and Disis ML
Journal:
Annals of the New York Academy of Sciences
Volume:
1174
Page:
81-7
Pubmed:
Original Article
Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor
Cancer Diagnostics
2009
Authors:
Ladd J, Lu H, Taylor AD, Goodell V, Disis ML, Jiang S
Journal:
Colloids and Surfaces B: Biointerfaces
Volume:
70(1)
Page:
1-6
Pubmed:
Original Article
Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer
Cancer Diagnostics
2008
Authors:
Lu H, Goodell V, and Disis ML
Journal:
Journal of Proteome Research
Volume:
7(4)
Page:
1388-94
Pubmed:
Original Article
An analytical workflow for investigating cytokine profiles
Measuring Human Immunity
2008
Authors:
Siebert JC, Inokuma M, Waid DM, Pennock ND, Vaitaitis GM, Disis ML, Dunne JF, Wagner DH and Maecker HT
Journal:
Cytometry A
Volume:
73(4)
Page:
289-98
Pubmed:
Original Article
The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity
Tumor Microenvironment
2008
Authors:
Behrens MD, Wagner WM, Krco CJ, Erskine CL, Kalli KR, Krempski J, Gad EA, Disis ML and Knutson KL
Journal:
Blood
Volume:
111(3)
Page:
1472-9
Pubmed:
Original Article
His-tag ELISA for the detection of humoral tumor-specific immunity
Cancer Diagnostics
2008
Authors:
Goodell V, McNeel D and Disis ML
Journal:
BMC Immunology
Volume:
9
Page:
23
Pubmed:
Original Article
Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer
Cancer Vaccines
2008
Authors:
Park KH, Gad E, Goodell V, Dang Y, Wild T, Higgins D, Fintak P, Childs J, Dela Rosa C, Disis ML
Journal:
Cancer Research
Volume:
68(20)
Page:
8400-9
Pubmed:
Original Article
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity
Cancer Vaccines
2008
Authors:
Goodell V, Waisman J, Salazar LG, dela Rosa C, Link J, Coveler AL, Webster W, Childs JS, Fintak PA, Higgins DM and Disis ML
Journal:
Molecular Cancer Therapeutics
Volume:
7(3)
Page:
449-54
Pubmed:
Original Article
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer
Cancer Vaccines
2008
Authors:
Kalli KR, Krco CJ, Hartmann LC, Goodman K, Maurer MJ, Yu C, Johnson EM, Erskine CL, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL
Journal:
Cancer Research
Volume:
68(12)
Page:
4893-901
Pubmed: